Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4

被引:0
|
作者
Jinju Yang
Nannan Qin
Hongwei Zhang
Rui Yang
Benqiong Xiang
Qun Wei
机构
[1] Beijing Normal University,Department of Biochemistry and Molecular Biology
[2] Gene Engineering and Biotechnology Beijing Key Laboratory,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Our previous research showed that recombinant calcineurin B (rhCnB) stimulates cytokine secretion by immune cells, probably through TLR4. Exogenous CnB can be incorporated into many different tumour cells in vitro, but the mode of uptake and receptors required remain unknown. Here, we report that exogenous CnB is taken up by cells in a time- and concentration-dependent manner via clathrin-dependent receptor-mediated internalization. Our findings further confirm that uptake is mediated by the TLR4/MD2 complex together with the co-receptor CD14. The MST results revealed a high affinity between CnB and the TLR4 receptor complex. No binding was detected between CnB and LPS. CnB inhibited the uptake of LPS, and LPS also inhibited the uptake of CnB. These results indicate that the uptake of exogenous CnB did not occur through LPS and that CnB was not a chaperone of LPS. Thus, we conclude that TLR4 receptor complexes were required for the recognition and internalization of exogenous CnB. CnB could be a potential endogenous ligand of TLR4 and function as an agonist of TLR4. These properties of CnB support its potential for development as an anti-cancer drug.
引用
收藏
相关论文
共 50 条
  • [21] Artesunate: attenuating TLR4/MD2 signaling to alleviate cardiac fibrosis
    Koch, Lars
    Hoeft, Konrad
    Kramann, Rafael
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [22] Soluble MD2 increases TLR4 levels on the epithelial cell surface
    Lauer, Sabine
    Kunde, Yuliya A.
    Apodaca, Theresa A.
    Goldstein, Byron
    Hong-Geller, Elizabeth
    CELLULAR IMMUNOLOGY, 2009, 255 (1-2) : 8 - 16
  • [23] Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88
    Blednov, Yuri A.
    Black, Mendy
    Chernis, Julia
    Da Costa, Adriana
    Mayfield, Jody
    Harris, R. Adron
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 (03) : 516 - 530
  • [24] Retinol-Binding Protein 4 (RBP4) Signals Through TLR2 and TLR4/MD2
    Yore, Mark M.
    Aryal, Pratik
    Kahn, Barbara B.
    DIABETES, 2012, 61 : A423 - A424
  • [25] HMGB1 BINDS TO MD2 IN THE TLR4/MD2 COMPLEX TO ELICIT INFLAMMATORY RESPONSES
    Yang, H.
    Ochani, M.
    Rosas, M.
    Li, J.
    Lu, B.
    Chavan, S.
    Tracey, K. J.
    SHOCK, 2011, 35 : 33 - 33
  • [26] MD2 Inhibits Choroidal Neovascularization via Antagonizing TLR4/MD2 Mediated Signaling Pathway
    Wu, Qi
    Chen, Zhang
    Wu, Chenxin
    Zhang, Lingxi
    Wu, Yuyang
    Liu, Xiyuan
    Wang, Yi
    Zhang, Zongduan
    CURRENT EYE RESEARCH, 2023, 48 (05) : 474 - 484
  • [27] The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane
    Tanimura, Natsuko
    Saitoh, Shin-ichiroh
    Ohto, Umeharu
    Akashi-Takamura, Sachiko
    Fujimoto, Yukari
    Fukase, Koichi
    Shimizu, Toshiyuki
    Miyake, Kensuke
    INTERNATIONAL IMMUNOLOGY, 2014, 26 (06) : 307 - 314
  • [28] TLR4/CD14/MD2 Revealed as the Limited Toll-like Receptor Complex for Chlamydia trachomatis-Induced NF-κB Signaling
    Klasinc, Romana
    Battin, Claire
    Paster, Wolfgang
    Reiter, Michael
    Schatzlmaier, Philipp
    Rhein, Peter
    Spittler, Andreas
    Steinberger, Peter
    Stockinger, Hannes
    MICROORGANISMS, 2022, 10 (12)
  • [29] MD2 and CD14 mediate toll-like receptor 4 (TLR4) activation by high mobility group box 1 (HMGB1)
    Mollen, Kevin
    Mollen, Kevin
    Kaczorowski, David
    Yoneyama, Toshie
    Vallabhaneni, Raghuveer
    Kilgore, Tina
    Bo, Meihua
    Lotze, Michael
    Billiar, Timothy
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 205 (03) : S28 - S28
  • [30] CD14、TLR4判断癌症患者病情的研究
    黄金
    吉利娜
    张永亮
    陈妍
    裴毅
    中国医学创新, 2011, 8 (01) : 143 - 144